T. Rowe Price Investment Management »

Bridgebio Pharma shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $26M 996k 26.37

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Fortive Corp Comm Stk (FTV)
Ingersoll Rand Comm Stk (IR)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOGL)
Amazon Comm Stk (AMZN)
Yum Brands Comm Stk (YUM)
Microchip Technology Comm Stk (MCHP)
Intercontinental Exchange In Comm Stk (ICE)
Apple Comm Stk (AAPL)
Becton Dickinson & Co Comm Stk (BDX)
Hologic Comm Stk (HOLX)
Avantor Comm Stk (AVTR)
Hilton Worldwide Hldgs Comm Stk (HLT)
Revvity Comm Stk (RVTY)

View all positions for T. Rowe Price Investment Management

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma